This document discusses the impact of male factors on recurrent pregnancy loss (RPL). It notes that while the female is typically evaluated extensively for causes of RPL, the male contribution is often overlooked except for karyotyping. However, the male genome contributes half of the genetic material to embryos and animal studies suggest the male is important for placental development. Possible male causes of RPL discussed include chromosomal abnormalities in sperm (structural or numerical), gene mutations, and sperm quality issues. The document advocates for more extensive evaluation of genetic factors in both males and females to better understand RPL.
Recurrent implantation failure: British fertility society Guidelines2020Aboubakr Elnashar
This document discusses recurrent implantation failure (RIF) in IVF treatment. It covers investigations and causes of RIF including endometrial factors, gamete/embryo quality issues, and other potential causes. Treatment options are also reviewed addressing endometrial issues, improving gametes and embryos, lifestyle changes, and embryo transfer techniques. The document provides guidelines on RIF management based on levels of evidence.
Role of Stem Cells in Obstetrics and Gynecology PracticeAsha Jain
Role of Stem Cells in Obstetrics and Gynecology Practice
Talk delivered at 4th Biennial International ISCSGCON 2021
on Febuary 13,2021 by Dr. Asha Jain
Uterus Transplantation Utx (obstetric and gynecology) D.A.B.M
Is the surgical procedure whereby a healthy uterus is transplanted into an organism of which the uterus is absent or diseased.
As part of normal mammalian sexual reproduction, a diseased or absent uterus does not allow normal embryonic implantation, effectively rendering the female infertile.
This phenomenon is known as Absolute Uterine Factor Infertility (AUFI).
Uterine transplant is a potential treatment for this form of infertility.
Uterus is a dynamic, complex organ. It is hugely blood-flow dependent.
More than 116,000 Number of men, women and children on the national transplant waiting list as of August 2017.
33,611 transplants were performed in 2016.
20 people die each day waiting for a transplant.
every 10 minutes another person is added to the waiting list.
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)Sujoy Dasgupta
Dr Sujoy Dasgupta invited to deliver a lecture on "RPL- ESHRE Guideline" in the Annual Conference of RCOG (Royal College of Obstetricians and Gynaecologists) IRC (International Representative Committee) India East held on 20-21 May, 2023
OVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANIDR SHASHWAT JANI
The document discusses ovarian rejuvenation using platelet-rich plasma (PRP) injections. PRP is extracted from a patient's own blood and contains growth factors that may reawaken dormant follicles in the ovaries. The procedure involves extracting blood, centrifuging it to separate PRP from other blood components, and injecting the PRP into the ovaries under ultrasound guidance, usually once a month for three months. The goal is to stimulate egg maturation and development, helping patients conceive. Side effects are minimal and may include pain, fever, or internal bleeding. Follow-up monitors hormone levels to check for signs of improved ovarian function.
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLESAboubakr Elnashar
This document discusses different methods for endometrial preparation in frozen embryo transfer (FET) cycles. It describes natural cycle FET, which can be done through a true natural cycle or modified natural cycle with an HCG trigger. It also outlines artificial/hormone replacement cycle FET, where estrogen and progesterone are administered without GnRH agonists in patients with remaining ovarian function. The key points are that the endometrium must be adequately prepared prior to embryo transfer, and the age of the embryos after thawing should correspond to the developmental age of the endometrium. The best method varies between patients and there is no clear consensus.
This document provides biographical information about Dr. Narendra Malhotra, an obstetrician and gynecologist from India. It lists his professional roles and accomplishments, which include being president of FOGSI, dean of ICMU, director of the Ian Donald School of Ultrasound, and editor of several medical books and journals. It also provides contact information for Malhotra Hospitals in Agra, India, where Dr. Malhotra practices and serves as a consultant for IVF procedures in several other cities.
Panel Discussion Problems of MALE INFERTILITY & Management of Oligo Astheno T...Lifecare Centre
This document summarizes a panel discussion on male infertility and the management of oligo astheno teratospermia (OAT). The panel included urologists, IVF experts, and gynaecologists who discussed topics such as the causes of male infertility, recent WHO criteria for semen analysis, what constitutes OAT, specific and idiopathic causes of OAT, how smoking affects fertility, and the steps in evaluating a male for infertility including history, examination, semen analysis, hormone assays, ultrasound, and additional tests or procedures when indicated.
Recurrent implantation failure: British fertility society Guidelines2020Aboubakr Elnashar
This document discusses recurrent implantation failure (RIF) in IVF treatment. It covers investigations and causes of RIF including endometrial factors, gamete/embryo quality issues, and other potential causes. Treatment options are also reviewed addressing endometrial issues, improving gametes and embryos, lifestyle changes, and embryo transfer techniques. The document provides guidelines on RIF management based on levels of evidence.
Role of Stem Cells in Obstetrics and Gynecology PracticeAsha Jain
Role of Stem Cells in Obstetrics and Gynecology Practice
Talk delivered at 4th Biennial International ISCSGCON 2021
on Febuary 13,2021 by Dr. Asha Jain
Uterus Transplantation Utx (obstetric and gynecology) D.A.B.M
Is the surgical procedure whereby a healthy uterus is transplanted into an organism of which the uterus is absent or diseased.
As part of normal mammalian sexual reproduction, a diseased or absent uterus does not allow normal embryonic implantation, effectively rendering the female infertile.
This phenomenon is known as Absolute Uterine Factor Infertility (AUFI).
Uterine transplant is a potential treatment for this form of infertility.
Uterus is a dynamic, complex organ. It is hugely blood-flow dependent.
More than 116,000 Number of men, women and children on the national transplant waiting list as of August 2017.
33,611 transplants were performed in 2016.
20 people die each day waiting for a transplant.
every 10 minutes another person is added to the waiting list.
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)Sujoy Dasgupta
Dr Sujoy Dasgupta invited to deliver a lecture on "RPL- ESHRE Guideline" in the Annual Conference of RCOG (Royal College of Obstetricians and Gynaecologists) IRC (International Representative Committee) India East held on 20-21 May, 2023
OVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANIDR SHASHWAT JANI
The document discusses ovarian rejuvenation using platelet-rich plasma (PRP) injections. PRP is extracted from a patient's own blood and contains growth factors that may reawaken dormant follicles in the ovaries. The procedure involves extracting blood, centrifuging it to separate PRP from other blood components, and injecting the PRP into the ovaries under ultrasound guidance, usually once a month for three months. The goal is to stimulate egg maturation and development, helping patients conceive. Side effects are minimal and may include pain, fever, or internal bleeding. Follow-up monitors hormone levels to check for signs of improved ovarian function.
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLESAboubakr Elnashar
This document discusses different methods for endometrial preparation in frozen embryo transfer (FET) cycles. It describes natural cycle FET, which can be done through a true natural cycle or modified natural cycle with an HCG trigger. It also outlines artificial/hormone replacement cycle FET, where estrogen and progesterone are administered without GnRH agonists in patients with remaining ovarian function. The key points are that the endometrium must be adequately prepared prior to embryo transfer, and the age of the embryos after thawing should correspond to the developmental age of the endometrium. The best method varies between patients and there is no clear consensus.
This document provides biographical information about Dr. Narendra Malhotra, an obstetrician and gynecologist from India. It lists his professional roles and accomplishments, which include being president of FOGSI, dean of ICMU, director of the Ian Donald School of Ultrasound, and editor of several medical books and journals. It also provides contact information for Malhotra Hospitals in Agra, India, where Dr. Malhotra practices and serves as a consultant for IVF procedures in several other cities.
Panel Discussion Problems of MALE INFERTILITY & Management of Oligo Astheno T...Lifecare Centre
This document summarizes a panel discussion on male infertility and the management of oligo astheno teratospermia (OAT). The panel included urologists, IVF experts, and gynaecologists who discussed topics such as the causes of male infertility, recent WHO criteria for semen analysis, what constitutes OAT, specific and idiopathic causes of OAT, how smoking affects fertility, and the steps in evaluating a male for infertility including history, examination, semen analysis, hormone assays, ultrasound, and additional tests or procedures when indicated.
Intrapartum sonography can be used to more accurately assess fetal head position, station, descent, and rotation during labor compared to digital examination alone. It also helps predict success of induction of labor and instrumental delivery. The document outlines the basic technique, objectives, and various clinical applications of intrapartum sonography during different stages of labor.
This document discusses different methods for endometrial preparation in frozen embryo transfer cycles. It summarizes that:
1) Natural cycles can be used for younger patients but have limitations like irregular cycles and difficulty timing ovulation.
2) Hormonally controlled cycles using estrogen and progesterone with or without GnRH agonists are effective options. Exogenous hormone administration without GnRH agonists is now commonly used as it is simple and effective.
3) Factors like embryo quality and endometrial thickness predict success, but preparation method, hormone type/administration, and cryostorage length do not affect outcomes. The best predictors are good quality embryos and a tri-laminar endometrial pattern.
interest in stem cells is raising in different field of medicine. The question is : is it successful in Gynecology or it is still too early to say that. The present talk may help to explore this .
IUI is a fertility treatment where sperm is placed directly in the uterus in order to facilitate fertilization and pregnancy. It is a simple, minimally invasive procedure that is often the first treatment for infertility. Factors like the woman's age, the cause of infertility, and the stimulation protocol used can affect the success rate, which typically ranges from 5-30%. The process involves ovarian stimulation, monitoring follicle development, sperm preparation using techniques like density gradient centrifugation, and then precisely timing insemination around ovulation to increase the chances of conception.
Laparoscopic ovarian drilling (LOD) is an alternative treatment for women with polycystic ovarian syndrome (PCOS) who are resistant to clomiphene citrate ovulation induction. LOD involves using electrocautery or laser energy to create multiple small openings in the ovarian capsule. This surgical trauma restores hypothalamic-pituitary-ovarian function and results in ovulation rates of 50-90% and pregnancy rates of 64-76%. LOD avoids risks of multiple pregnancy and ovarian hyperstimulation syndrome associated with gonadotropin treatments, and results in sustained fertility benefits for several years with minimal risks. Guidelines recommend LOD as a first-line treatment alternative to gonadotrop
This document provides guidelines for the diagnosis and management of premature ovarian insufficiency (POI). It defines POI as depletion of follicular activity before age 40, characterized by menstrual disturbances, raised gonadotropins, and low estrogen. The prevalence is approximately 1% in the general population. Causes include genetic factors, autoimmune disorders, infections, chemotherapy and radiation. Management focuses on hormone replacement therapy (HRT) to reduce long-term health risks, fertility options, and treatment of symptoms like reduced bone mineral density and increased cardiovascular risk.
UNEXPLAINED INFERTILITY &INTRAUTERINE INSEMINATION Dr. Sharda jain Lifecare...Lifecare Centre
UNEXPLAINED INFERTILITY &INTRAUTERINE INSEMINATION DR. SHARDA JAIN , DR. JYOTI AGARWAL
DR. JYOTI BHASKAR
DEFINITION
Unexplained infertility means that couple does not conceive after 1year of unprotected vaginal sexual intercourse, with basic infertility evaluation showing no obvious abnormality.
INCIDENCE
15%to 20% of infertile couples
UNEXPLAINED IS PRIMARILY A
DIAGNOSIS OF EXCLUSION
EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT? Rahul Sen
This document discusses various methods for assessing embryo quality and selecting the best embryo for transfer, including traditional morphology assessment, kinetic/time-lapse imaging assessment, pre-implantation genetic testing, and 'omics' techniques. It emphasizes that traditional morphology alone provides limited information and that incorporating multiple parameters like developmental timing, fragmentation levels, and ploidy status can improve embryo selection and lead to higher implantation and pregnancy rates.
Laparoscopy still remains an important diagnostic and therapeutic tool in the management of subfertile women. Optimal and prudent use of this minimally invasive technique may avert costly treatment like IVF but overzealous and unindicated use may compromise future fertility. The evidence indicates that laparoscopic surgery improves fertility outcomes for conditions like mild to moderate endometriosis, myomectomy for submucosal fibroids, and tubal surgery. However, more high-quality randomized controlled trials are needed to provide stronger evidence and guidelines for clinical practice in reproductive surgery.
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...DR SHASHWAT JANI
This document discusses optimizing success with intrauterine insemination (IUI). It lists male and female factors that can indicate IUI, including issues like retrograde ejaculation or cervical hostility. Standard protocols for IUI are discussed, including using clomiphene, gonadotropins, or a combination. The timing of hCG administration and IUI is outlined. Techniques for sperm preparation and factors affecting IUI success rates are also summarized. Limitations of IUI are noted.
IUI remains an effective treatment option for certain fertility issues like unexplained infertility, mild male factor infertility, and infertility due to cervical factors. Stimulated IUI cycles have higher success rates than natural cycles. Optimal timing of IUI is 36-40 hours after hCG administration. IUI can be considered for poor responders to IVF as an alternative to cancellation. Success rates of IUI decline significantly after age 40. IUI may not be as effective as IVF for cases involving distal unilateral tubal blockage or hydrosalpinx. Strict protocols should be followed when performing IUI for HIV discordant couples.
Fertility preservation options are important for cancer patients of reproductive age undergoing treatment. For women, established options include embryo freezing for married patients and oocyte freezing for single patients, both of which require delaying cancer treatment. Ovarian tissue freezing can be done at any age or relationship status and does not delay treatment, but reimplantation success is currently low. For pre-pubertal patients, ovarian tissue or testicular tissue freezing are the only available options. Future methods may allow in vitro gamete maturation or stem cell derived gametes. Multidisciplinary care and individualized counseling are key to help patients preserve their fertility whenever possible before cancer treatment.
The document discusses changing protocols for in vitro fertilization (IVF) from gonadotropin-releasing hormone (GnRH) agonists to GnRH antagonists. Some key points discussed include:
1) GnRH antagonists are associated with a lower risk of ovarian hyperstimulation syndrome (OHSS) compared to GnRH agonists.
2) While efficacy outcomes like live birth and pregnancy rates are similar between the two protocols, GnRH antagonists require fewer gonadotropin ampoules and have a shorter duration of stimulation.
3) Based on multiple randomized controlled trials and meta-analyses, it is justified to shift from GnRH agonists to GnRH antagonists for IVF
- Tumor markers are glycoproteins detected by monoclonal antibodies that are produced by tumors or the body's response to cancer.
- Cancer antigen 125 (CA-125) is an important tumor marker used for ovarian cancer screening, diagnosis, treatment monitoring and recurrence detection, though it can be elevated in some non-cancerous conditions.
- For screening, CA-125 levels above 35 U/mL in postmenopausal women or 200 U/mL in premenopausal women should be further evaluated. Monitoring CA-125 after treatment can indicate response or recurrence of ovarian cancer.
This document discusses various surgical sperm retrieval techniques for assisted reproduction, including:
1) Percutaneous epididymal sperm aspiration (PESA) and microsurgical epididymal sperm aspiration (MESA) are used to retrieve sperm from the epididymis in cases of obstructive azoospermia.
2) Testicular sperm aspiration (TESA) and testicular sperm extraction (TESE) are used to retrieve sperm directly from the testes in cases of non-obstructive azoospermia or previous failed epididymal sperm retrieval.
3) Microsurgical testicular sperm extraction (Micro-TESE) uses an operating microscope to identify and extract semin
This document provides an overview of intrauterine insemination (IUI). Some key points include:
IUI is a first-line, non-invasive fertility treatment that involves placing processed sperm directly into the uterus. Success rates range from 6-20% depending on the stimulation protocol used. Factors like age, infertility duration and etiology, and semen quality impact success rates. Strict monitoring is important to minimize risks of ovarian hyperstimulation syndrome while maximizing pregnancy chances. Proper sperm processing techniques and timing of insemination relative to ovulation are also important considerations for IUI.
this presentation highlights the principles of uterine and ovarian transplantation. It explores the past and examines the current status for uterine and ovarian factor infertility.
This document summarizes a presentation on platelet rich plasma (PRP) in reproductive medicine. PRP is prepared through centrifugation of blood and contains high concentrations of growth factors and cytokines. The presentation reviews studies on intraovarian and intrauterine uses of PRP. For intraovarian use, PRP has shown promise in improving ovarian function in women with diminished ovarian reserve or poor responders. For intrauterine use, PRP may improve endometrial growth and pregnancy outcomes in women with thin endometrium or repeated implantation failure. However, the studies to date have been small case series and reports. Larger, randomized controlled trials are still needed to confirm the efficacy and safety of PRP for reproductive applications.
Chromosomal Abnormalities in a Male Partner Who was a Candidate for Assisted ...Apollo Hospitals
A 30-year-old man presented with 5 years of infertility. Cytogenetic analysis revealed a chromosomal translocation between chromosomes 1 and 21 in the male [46, XY t (1; 21) (q32; q22)], which was likely the cause of his infertility. The female partner showed a normal karyotype. Chromosomal abnormalities are a known cause of male infertility and genetic testing is recommended for infertile men prior to assisted reproduction techniques to identify abnormalities. The couple was counseled on their options which included assisted reproduction followed by preimplantation genetic diagnosis.
Recurrent pregnancy loss is defined as the loss of three or more consecutive pregnancies. It can be caused by anatomical, genetic, infectious, immune, or other factors. Common anatomical causes include uterine abnormalities like septate uterus and fibroids. Genetic factors may include chromosomal abnormalities in the products of conception or balanced translocations in one or both parents. Infectious causes like bacterial vaginosis can also contribute. The immune condition antiphospholipid antibody syndrome, characterized by antibodies that cause blood clots, increases the risk of recurrent loss. Treatment depends on the underlying cause but may include surgery to correct uterine anomalies, antibiotics for infections, low-dose aspirin with or without heparin for antiphospholip
Intrapartum sonography can be used to more accurately assess fetal head position, station, descent, and rotation during labor compared to digital examination alone. It also helps predict success of induction of labor and instrumental delivery. The document outlines the basic technique, objectives, and various clinical applications of intrapartum sonography during different stages of labor.
This document discusses different methods for endometrial preparation in frozen embryo transfer cycles. It summarizes that:
1) Natural cycles can be used for younger patients but have limitations like irregular cycles and difficulty timing ovulation.
2) Hormonally controlled cycles using estrogen and progesterone with or without GnRH agonists are effective options. Exogenous hormone administration without GnRH agonists is now commonly used as it is simple and effective.
3) Factors like embryo quality and endometrial thickness predict success, but preparation method, hormone type/administration, and cryostorage length do not affect outcomes. The best predictors are good quality embryos and a tri-laminar endometrial pattern.
interest in stem cells is raising in different field of medicine. The question is : is it successful in Gynecology or it is still too early to say that. The present talk may help to explore this .
IUI is a fertility treatment where sperm is placed directly in the uterus in order to facilitate fertilization and pregnancy. It is a simple, minimally invasive procedure that is often the first treatment for infertility. Factors like the woman's age, the cause of infertility, and the stimulation protocol used can affect the success rate, which typically ranges from 5-30%. The process involves ovarian stimulation, monitoring follicle development, sperm preparation using techniques like density gradient centrifugation, and then precisely timing insemination around ovulation to increase the chances of conception.
Laparoscopic ovarian drilling (LOD) is an alternative treatment for women with polycystic ovarian syndrome (PCOS) who are resistant to clomiphene citrate ovulation induction. LOD involves using electrocautery or laser energy to create multiple small openings in the ovarian capsule. This surgical trauma restores hypothalamic-pituitary-ovarian function and results in ovulation rates of 50-90% and pregnancy rates of 64-76%. LOD avoids risks of multiple pregnancy and ovarian hyperstimulation syndrome associated with gonadotropin treatments, and results in sustained fertility benefits for several years with minimal risks. Guidelines recommend LOD as a first-line treatment alternative to gonadotrop
This document provides guidelines for the diagnosis and management of premature ovarian insufficiency (POI). It defines POI as depletion of follicular activity before age 40, characterized by menstrual disturbances, raised gonadotropins, and low estrogen. The prevalence is approximately 1% in the general population. Causes include genetic factors, autoimmune disorders, infections, chemotherapy and radiation. Management focuses on hormone replacement therapy (HRT) to reduce long-term health risks, fertility options, and treatment of symptoms like reduced bone mineral density and increased cardiovascular risk.
UNEXPLAINED INFERTILITY &INTRAUTERINE INSEMINATION Dr. Sharda jain Lifecare...Lifecare Centre
UNEXPLAINED INFERTILITY &INTRAUTERINE INSEMINATION DR. SHARDA JAIN , DR. JYOTI AGARWAL
DR. JYOTI BHASKAR
DEFINITION
Unexplained infertility means that couple does not conceive after 1year of unprotected vaginal sexual intercourse, with basic infertility evaluation showing no obvious abnormality.
INCIDENCE
15%to 20% of infertile couples
UNEXPLAINED IS PRIMARILY A
DIAGNOSIS OF EXCLUSION
EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT? Rahul Sen
This document discusses various methods for assessing embryo quality and selecting the best embryo for transfer, including traditional morphology assessment, kinetic/time-lapse imaging assessment, pre-implantation genetic testing, and 'omics' techniques. It emphasizes that traditional morphology alone provides limited information and that incorporating multiple parameters like developmental timing, fragmentation levels, and ploidy status can improve embryo selection and lead to higher implantation and pregnancy rates.
Laparoscopy still remains an important diagnostic and therapeutic tool in the management of subfertile women. Optimal and prudent use of this minimally invasive technique may avert costly treatment like IVF but overzealous and unindicated use may compromise future fertility. The evidence indicates that laparoscopic surgery improves fertility outcomes for conditions like mild to moderate endometriosis, myomectomy for submucosal fibroids, and tubal surgery. However, more high-quality randomized controlled trials are needed to provide stronger evidence and guidelines for clinical practice in reproductive surgery.
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...DR SHASHWAT JANI
This document discusses optimizing success with intrauterine insemination (IUI). It lists male and female factors that can indicate IUI, including issues like retrograde ejaculation or cervical hostility. Standard protocols for IUI are discussed, including using clomiphene, gonadotropins, or a combination. The timing of hCG administration and IUI is outlined. Techniques for sperm preparation and factors affecting IUI success rates are also summarized. Limitations of IUI are noted.
IUI remains an effective treatment option for certain fertility issues like unexplained infertility, mild male factor infertility, and infertility due to cervical factors. Stimulated IUI cycles have higher success rates than natural cycles. Optimal timing of IUI is 36-40 hours after hCG administration. IUI can be considered for poor responders to IVF as an alternative to cancellation. Success rates of IUI decline significantly after age 40. IUI may not be as effective as IVF for cases involving distal unilateral tubal blockage or hydrosalpinx. Strict protocols should be followed when performing IUI for HIV discordant couples.
Fertility preservation options are important for cancer patients of reproductive age undergoing treatment. For women, established options include embryo freezing for married patients and oocyte freezing for single patients, both of which require delaying cancer treatment. Ovarian tissue freezing can be done at any age or relationship status and does not delay treatment, but reimplantation success is currently low. For pre-pubertal patients, ovarian tissue or testicular tissue freezing are the only available options. Future methods may allow in vitro gamete maturation or stem cell derived gametes. Multidisciplinary care and individualized counseling are key to help patients preserve their fertility whenever possible before cancer treatment.
The document discusses changing protocols for in vitro fertilization (IVF) from gonadotropin-releasing hormone (GnRH) agonists to GnRH antagonists. Some key points discussed include:
1) GnRH antagonists are associated with a lower risk of ovarian hyperstimulation syndrome (OHSS) compared to GnRH agonists.
2) While efficacy outcomes like live birth and pregnancy rates are similar between the two protocols, GnRH antagonists require fewer gonadotropin ampoules and have a shorter duration of stimulation.
3) Based on multiple randomized controlled trials and meta-analyses, it is justified to shift from GnRH agonists to GnRH antagonists for IVF
- Tumor markers are glycoproteins detected by monoclonal antibodies that are produced by tumors or the body's response to cancer.
- Cancer antigen 125 (CA-125) is an important tumor marker used for ovarian cancer screening, diagnosis, treatment monitoring and recurrence detection, though it can be elevated in some non-cancerous conditions.
- For screening, CA-125 levels above 35 U/mL in postmenopausal women or 200 U/mL in premenopausal women should be further evaluated. Monitoring CA-125 after treatment can indicate response or recurrence of ovarian cancer.
This document discusses various surgical sperm retrieval techniques for assisted reproduction, including:
1) Percutaneous epididymal sperm aspiration (PESA) and microsurgical epididymal sperm aspiration (MESA) are used to retrieve sperm from the epididymis in cases of obstructive azoospermia.
2) Testicular sperm aspiration (TESA) and testicular sperm extraction (TESE) are used to retrieve sperm directly from the testes in cases of non-obstructive azoospermia or previous failed epididymal sperm retrieval.
3) Microsurgical testicular sperm extraction (Micro-TESE) uses an operating microscope to identify and extract semin
This document provides an overview of intrauterine insemination (IUI). Some key points include:
IUI is a first-line, non-invasive fertility treatment that involves placing processed sperm directly into the uterus. Success rates range from 6-20% depending on the stimulation protocol used. Factors like age, infertility duration and etiology, and semen quality impact success rates. Strict monitoring is important to minimize risks of ovarian hyperstimulation syndrome while maximizing pregnancy chances. Proper sperm processing techniques and timing of insemination relative to ovulation are also important considerations for IUI.
this presentation highlights the principles of uterine and ovarian transplantation. It explores the past and examines the current status for uterine and ovarian factor infertility.
This document summarizes a presentation on platelet rich plasma (PRP) in reproductive medicine. PRP is prepared through centrifugation of blood and contains high concentrations of growth factors and cytokines. The presentation reviews studies on intraovarian and intrauterine uses of PRP. For intraovarian use, PRP has shown promise in improving ovarian function in women with diminished ovarian reserve or poor responders. For intrauterine use, PRP may improve endometrial growth and pregnancy outcomes in women with thin endometrium or repeated implantation failure. However, the studies to date have been small case series and reports. Larger, randomized controlled trials are still needed to confirm the efficacy and safety of PRP for reproductive applications.
Chromosomal Abnormalities in a Male Partner Who was a Candidate for Assisted ...Apollo Hospitals
A 30-year-old man presented with 5 years of infertility. Cytogenetic analysis revealed a chromosomal translocation between chromosomes 1 and 21 in the male [46, XY t (1; 21) (q32; q22)], which was likely the cause of his infertility. The female partner showed a normal karyotype. Chromosomal abnormalities are a known cause of male infertility and genetic testing is recommended for infertile men prior to assisted reproduction techniques to identify abnormalities. The couple was counseled on their options which included assisted reproduction followed by preimplantation genetic diagnosis.
Recurrent pregnancy loss is defined as the loss of three or more consecutive pregnancies. It can be caused by anatomical, genetic, infectious, immune, or other factors. Common anatomical causes include uterine abnormalities like septate uterus and fibroids. Genetic factors may include chromosomal abnormalities in the products of conception or balanced translocations in one or both parents. Infectious causes like bacterial vaginosis can also contribute. The immune condition antiphospholipid antibody syndrome, characterized by antibodies that cause blood clots, increases the risk of recurrent loss. Treatment depends on the underlying cause but may include surgery to correct uterine anomalies, antibiotics for infections, low-dose aspirin with or without heparin for antiphospholip
Sperm DNA Fragmentation : Role in natural and assisted conception: Recent adv...Shivani Sachdev
Male factor infertility is responsible for >40% of couples presenting for ART. Conventional SA continues to be the only routine test to diagnose this condition. Current SA is based on 5th edition of the WHO manual (2010) . All normal values shifted to lower centile compared to previous edition. Less men now classified as infertile (Murray et al 2012). Sperm DNA damage - used to denote abnormal genetic material which in turn may lead to male sub fertility/ IVF failure / miscarriage.
DNA Fragmentation Index of Sperm - Expressed as DFI- or percentage of the number of cells with defects in protamination of DNA structure in the evaluated sperm cells
The integrity of paternal genome is of paramount importance in the initiation of viable pregnancy. The fragmented DNA is incompatible with normal embryonic development
Sperm chromatin anomalies are often present in men with abnormal semen analyses 8% of men with normal semen parameters have abnormal sperm DNA integrity
Zini A.Biologic variability of sperm DNA denaturation in infertile men. Urology 2001
We discuss the various tests used and recent concepts and techniques and what are the newer treatment options
Male factors can contribute to recurrent pregnancy loss (RPL). Abnormal sperm morphology, functions, and DNA as well as varicoceles, infections, and advanced paternal age are associated with increased risk of RPL. Evaluating sperm parameters, functions like DNA integrity, and aneuploidy can help identify male factors contributing to RPL. Both partners should be screened to improve outcomes with assisted reproductive technologies or lifestyle changes like antioxidant supplementation.
Human reproduction is remarkably inefficient; Only 420 are born alive out of 1000 fertilizations, nearly 70% of human conceptions do not survive to live birth. The stillbirth in india is highest in the world 7% to 14% in different states Odisha 8% Karnataka 14% (of course reported only) Recurrent pregnancy loss is a psychologically stressful diagnosis for couples, in approximately 50% of cases, no cause will be found. The number of evidence-based practices available for guidance is limited. This confluence of factors presents a challenge for clinicians. However, in studies of interventions aimed at reducing rates of miscarriage in women with otherwise unexplained RPL, control groups experience a live birth rate of up to 87% with no intervention. Thus, one of the most significant things we can do when caring for these complex patients is to offer them emotional support and accurate information. As more work is done in this emerging area of reproductive science, we will be able to shed more light on this complex problem.
1) The study analyzed over 10,000 chromosomes in embryos and oocytes from 44 patients carrying Robertsonian translocations and over 200,000 chromosomes in control samples to conclusively determine if an inter-chromosomal effect (ICE) exists.
2) The results showed a highly significant increase in abnormal segregation of structurally normal chromosomes in embryos, but not oocytes, of female carriers, indicating a mitotic rather than meiotic origin of the ICE.
3) The findings have implications for understanding genetic stability during early embryo development and are clinically relevant for patients carrying Robertsonian translocations.
1) The study analyzed over 10,000 chromosomes in embryos and oocytes from 44 patients carrying Robertsonian translocations and over 200,000 chromosomes in control samples to conclusively determine if an inter-chromosomal effect (ICE) exists.
2) The results showed a highly significant increase in abnormal segregation of structurally normal chromosomes in embryos, but not oocytes, of female carriers, indicating a mitotic rather than meiotic origin of the ICE.
3) The findings have implications for understanding genetic stability during early human development and are clinically relevant for patients carrying Robertsonian translocations.
1) The study analyzed over 10,000 chromosomes in embryos and oocytes from 44 patients carrying Robertsonian translocations and over 200,000 chromosomes in control samples to conclusively determine if an inter-chromosomal effect (ICE) exists.
2) The results showed a highly significant increase in abnormal segregation of structurally normal chromosomes in embryos, but not oocytes, of female carriers, indicating a mitotic rather than meiotic origin of the ICE.
3) The findings have implications for understanding genetic stability during early human development and are clinically relevant for patients carrying Robertsonian translocations.
The document discusses a genetic test called iMGE Test that analyzes miscarriage material to identify chromosomal defects that may cause pregnancy loss. The test uses next generation sequencing to analyze all chromosomes simultaneously and does not require cell culture, providing results for over 95% of cases. Identifying genetic causes can help guide family planning decisions and determine if preimplantation genetic diagnosis would be beneficial for couples seeking to avoid miscarriage in future pregnancies. The test is recommended after miscarriage for women over 35, those with a family history of genetic defects, or couples with a history of infertility or recurrent miscarriage.
'GENETICS OF MALE & FEMALE INFERTILITY.pptxRahul Sen
This presentation briefs about an important aspect of infertility which deals about genes and its occurrence in future progeny. Genetics of Male & Female infertility which is not always discussed usually until unless a couple doesn't exhibit pregnancy losses or a major cause of infertility. lets read about Genetics of male and female infertility. Happy Reading <3
This document discusses sperm DNA fragmentation, which refers to breaks in sperm DNA. It notes that a high level of fragmentation can compromise the possibility of a successful pregnancy. While fragmentation does not seem to affect early embryo development, it can impact later stages. Fragmentation is associated with lower success rates for treatments like IUI, IVF, and ICSI. The document outlines various tests for measuring fragmentation and notes treatment options depend on the specific cause and severity of the fragmentation. Lifestyle changes may help in some cases by reducing oxidative stress, while varicocele repair or using testicular sperm extraction with ICSI may also improve outcomes.
This study examined the relationship between DNA damage and numerical chromosome abnormalities in sperm samples from 45 infertile men. The study found:
1) A significant correlation between the proportion of sperm with numerical chromosome abnormalities and the level of DNA fragmentation.
2) Sperm cells that were chromosomally abnormal were more likely to display DNA damage than those that were normal based on the chromosomes tested.
3) This association was detected not only in samples with elevated rates of chromosome abnormalities, but also in samples with rates in the normal range. The findings suggest DNA fragmentation may be a marker for the presence of chromosome abnormalities in sperm.
Sperm DNA Fragmentation Test , Dr. Sharda Jain Lifecare Centre Lifecare Centre
This document discusses sperm DNA fragmentation testing, which analyzes sperm DNA integrity. It notes that while normal semen analysis cannot differentiate between fertile and infertile men, sperm DNA damage is a key factor in male infertility. High levels of DNA fragmentation are associated with failed fertility treatments, recurrent miscarriages, and impaired embryo development and pregnancy outcomes. The document recommends testing for men with unexplained infertility, failed IVF/ICSI attempts, miscarriage history, risk factors for DNA damage, or poor semen quality. It provides cutoff points for DNA fragmentation index values and states that ICSI may improve success over IVF for men with DFI over 30%. The test aims to help identify treatable causes of infertility and improve assisted reproduction
E-Mail [email protected]Clinical Genetic Aspects of Consangu.docxsagarlesley
E-Mail [email protected]
Clinical Genetic Aspects of Consanguinity
Hum Hered 2014;77:108–117
DOI: 10.1159/000360763
Consanguinity and Disorders of
Sex Development
Anu Bashamboo Ken McElreavey
Human Developmental Genetics, Institut Pasteur, Paris , France
Introduction
Disorders of sex development (DSD) are defined as
‘congenital conditions in which the development of chro-
mosomal, gonadal, or anatomical sex is atypical’ [1] . DSD
has recently been coined to encompass terms such as in-
tersex, pseudohermaphroditism, hermaphroditism and
sex-reversal, which can be confusing to clinicians, pa-
tients and parents. The definition provides a rational ba-
sis for designating each phenotype. 46,XY DSD includes
errors of testis determination or undermasculinization of
an XY male due to errors in either androgen synthesis or
androgen action. 46,XY gonadal dysgenesis is an error of
testis determination that is either complete (complete go-
nadal dysgenesis; CGD) or partial (partial gonadal dys-
genesis; PGD). 46,XY CGD is characterized by complete-
ly female external genitalia, well-developed Müllerian
structures and a gonad composed of a streak of fibrous
tissue. On the other hand, 46,XY PGD is characterized by
partial testis formation, usually a mixture of Wolffian and
Müllerian ducts and varying degrees of masculinization
of the external genitalia. 46,XX DSD includes overviril-
ization or masculinization of an XX individual due to an-
drogen excess, and the vast majority of cases of 46,XX
DSD are associated with congenital adrenal hyperplasia
(CAH) [2] . The much rarer 46,XX testicular DSD refers
to a male with testes and a normal male habitus, whereas
46,XX ovotesticular DSD refers to individuals that have
Key Words
Consanguinity · Disorders of sex development
Abstract
Disorders of sex development (DSD) are defined as ‘congen-
ital conditions in which the development of chromosomal,
gonadal, or anatomical sex is atypical’ [Lee et al., Pediatrics
2006; 118:e488–e500]. Studies conducted in Western coun-
tries, with low rates of consanguinity, show that truly am-
biguous genitalia have an estimated incidence of 1: 5,000
births. There are indications that the prevalence of DSD is
higher in endogamous communities. The incidence of am-
biguous genitalia in Saudi Arabia has been estimated at
1: 2,500 live births; whilst in Egypt, it has been estimated at
1: 3,000 live births. This may be due in part to an increase in
disorders of androgen synthesis associated with 46,XX DSD.
There is clearly a need for further studies to address the fre-
quency of DSD in communities with high levels of consan-
guinity. This will be challenging, as an accurate diagnosis is
difficult and expensive even in specialized centres. In devel-
oping countries with high levels of consanguinity, these lim-
itations can be compounded by cultural, social and religious
factors. Overall there is an indication that consan ...
20150918 E. Pompilii - Microarray in diagnosi prenatale: la complessità della...Roberto Scarafia
Eva Pompilii, MD
Genetic Counselor , TOMA Advanced Biomedical Assays, S.p.A.,
Gynepro Medical Bologna, Policlinico S.Orsola Malpighi Bologna
• OBJECTIVES:
At present, a precise guideline establishing chromosome microarray analysis (CMA) applications and platforms in the prenatal setting does not exist. The actual controversial
question is whether CMA technologies can or should shortly replace the standard karyotype in prenatal diagnosis practice
• CONCLUSIONS:
Presently CMA analysis can be considered a second-tier diagnostic test to be used after a standard karyotype in selected group of pregnancies, such as those with single
(apparently isolated) or multiple US fetal abnormalities, with de novo chromosomal rearrangements, even if apparently balanced, and those with supernumerary markers chromosomes
This document provides information on Down syndrome (DS), including its causes, genetics, clinical features, diagnostic tests, and risk factors. DS, also known as trisomy 21, is caused most commonly by non-disjunction resulting in a third copy of chromosome 21. It causes intellectual disability and physical features such as a flat facial profile, upslanted eyes, and loose skin at the neck. Diagnosis is usually based on clinical features and confirmed through karyotyping, FISH, or prenatal screening/diagnostic tests. The risk of DS increases with maternal age and for mothers who previously had a child with DS.
Nontraditional inheritance refers to the pattern of inheritance of a trait or phenotype that occurs predictably, recurrently, and in some cases familially, but does not follow the rules of typical Mendelian autosomal or sex chromosome inheritance.
Key concepts:
1. Introduction
2. Triplet repeat expansion mutations
3. Anticipation
4. Mosaicism
5.Genomic imprinting
6. Uniparental disomy
7. Mitochondrial inheritance
8. Multi-allelic inheritance
1. Cesarean scar pregnancy (CSP) occurs when a gestational sac implants at the site of a previous cesarean section scar and can lead to life-threatening complications if not treated.
2. Ultrasound is the primary diagnostic tool and shows the gestational sac located in the scar without connecting to the uterine cavity.
3. Treatment options include expectant management, medical management with methotrexate, and surgical management ranging from uterine curettage to hysterectomy. The goal is to terminate the pregnancy while preserving the uterus and future fertility.
This document discusses methods for estimating gestational age, which is important for optimizing fetal surveillance and timing tests and activities. Gestational age can be estimated through history (last menstrual period, fertility treatments), clinical exam (fundal height, fetal tone), and ultrasound measurements. Ultrasound is the most accurate method, especially early crown-rump length. Later, biparietal diameter, head circumference, femur length, and abdominal circumference are measured but decrease in accuracy over time. Precise gestational age estimation allows for detecting preterm or post-term delivery as well as fetal growth abnormalities.
This document discusses androgen excess in females (hirsutism). It begins by defining hirsutism and virilization. It then covers the biology of hair growth and the roles of androgens and estrogens. It discusses the sources and metabolism of androgens in females. The main causes of hirsutism discussed are physiological puberty/pregnancy/menopause), idiopathic, ovarian (PCOS, tumors), and adrenal (CAH, tumors). The evaluation of hirsutism involves history, exam, and lab tests of hormones like testosterone and DHEA. Key tests aim to identify the underlying cause and assess for conditions like PCOS, tumors, CAH
This document provides an overview of thyroid function and disorders during pregnancy. It discusses how the thyroid gland and thyroid function tests change normally during pregnancy. It also covers hyperthyroidism and hypothyroidism in pregnancy, including their effects on the fetus and neonate. Key points include that both hyperthyroidism and hypothyroidism can lead to adverse pregnancy outcomes if not properly treated, and maternal thyroid antibodies can affect the fetal thyroid gland. Precise diagnosis and treatment of thyroid disorders is important for maternal and fetal health.
1. The document contains a series of questions and images related to obstetrics and gynecology. It covers topics like pelvic organ prolapse staging, uterine anomalies, cervical cancer staging, and laparoscopic procedures.
2. Many slides provide images asking the learner to identify procedures, abnormalities, or surgical findings. Other questions require identifying diagnoses and management plans based on clinical scenarios or exam results.
3. The document acts as a study guide, testing knowledge of common OB/GYN topics through visual aids and case-based questions.
This document contains questions from an OSCE revision on obstetrics and gynecology. It includes questions about various clinical maneuvers, fetal positions, indications for procedures, abnormalities interpreted from graphs and images, and complications in labor and delivery. The document seeks to assess knowledge of key obstetrical and gynecological topics through a series of clinical case examples and diagnostic questions.
This document contains a series of questions about obstetrics and gynecology. It covers topics like fetal positioning, maternal changes during pregnancy, fetal head diameters, malpresentations, fetal monitoring, labor induction techniques, placental abnormalities, and gynecological procedures. The questions are intended to help review content for an OSCE (objective structured clinical examination) in obstetrics and gynecology. There are over 30 slides with around 3-4 multiple choice or short answer questions on each slide covering various areas of prenatal care, labor and delivery, and gynecological exam skills and procedures.
This document contains a series of questions related to obstetrics and gynecology. It addresses topics like labor complications (shoulder dystocia, abnormal fetal lie), imaging findings (placental abnormalities, engagement/position of fetal head), surgical procedures (cervical cerclage, recurrent cesarean section), and labor patterns. Each section presents 1-4 multiple choice or short answer questions about the name, definition, risk factors, management, or differential diagnosis of a particular OB/GYN topic. The document is intended as a study aid for an OSCE (objective structured clinical examination) in obstetrics and gynecology.
1) Ovarian hyperstimulation syndrome (OHSS) is an exaggerated response to ovulation therapy that can range from mild to severe or even life-threatening. It is characterized by ovarian enlargement and fluid shift into the body's tissues.
2) Risk factors for OHSS include high AMH levels, PCOS, previous OHSS, and high follicle counts and estrogen levels during treatment. Clinicians must monitor for OHSS and be prepared to manage it.
3) Management strategies aim to prevent OHSS through individualized protocols, or to treat symptoms by delaying hCG, using lower hCG doses, cryopreserving all embryos, or cancelling cycles if needed. Secondary prevention after trigger includes
The document summarizes the anatomy of the fetal skull. It is formed of the face, vault, and base. The vault bones (frontal, parietal, occipital) are not fused, allowing the shape of the head to change during labor through molding. It defines anatomical locations like the fontanels and sutures. During birth, the fetal head undergoes molding where the bones overlap to reduce the head circumference as it descends through the pelvis. The degree of molding is rated from 0 to 3 based on the separation and overlap of the suture lines.
This document discusses shoulder, complex, and cord presentations during labor. It defines each type of presentation and provides information on incidence, etiology, diagnosis, and management. For shoulder presentations, the document outlines the 4 classical positions and explains that spontaneous vaginal delivery is impossible with a mature fetus due to lack of a mechanism for descent. It recommends external cephalic version during pregnancy or cesarean section. For complex presentations, the best treatment is typically masterful inactivity if labor is progressing normally, but cesarean section may be needed if progress arrests. Cord presentations carry risks of compression, so immediate delivery is usually recommended if the cervix is fully dilated.
- Palpates fetal back anteriorly.
- Applies counter pressure over fetal back to prevent version.
Obstetrician:
- Applies pressure over fetal presenting part (breech) to flex it.
- Applies pressure over fetal back to extend it.
- Applies pressure over fetal head to flex it.
- Rotates fetal presenting part out of pelvis.
- Rotates fetal head into pelvis.
• Version is complete when head engages.
Osama Warda 34
BREECH PRESENTATION- MANAGEMENT
BREECH
PRESENTATION-
MANAGEMENT
Osama
Ward
3 malpresentations.warda (3)- FACE PRESENTATIONOsama Warda
Face presentations occur when the fetal chin is the presenting part instead of the vertex. They are classified into four positions based on the position of the chin. Mentoanterior positions are more common and favorable than mentoposterior positions. Labor is usually prolonged in face presentations due to delayed engagement and lack of molding of the facial bones. Management depends on the position, with mentoanterior positions usually allowing vaginal delivery while mentoposterior positions often requiring assistance. Brow presentations are the rarest type and usually do not have a defined mechanism of labor.
1) Occiput posterior (OP) position occurs when the occiput of the fetal head is facing posteriorly during labor and delivery.
2) OP position is associated with a prolonged first stage of labor, delayed descent and engagement of the fetal head, and an increased risk of failed rotation requiring intervention.
3) Management of OP position focuses on encouraging rotation of the occiput to an anterior position during the second stage of labor. If rotation fails, interventions like manual rotation, forceps rotation, vacuum extraction, or cesarean section may be required.
1) Malpresentations occur when the fetus is positioned abnormally during delivery, with the most common normal positions being left or right occiput anterior. Malpositions involve a normal presentation (vertex) but abnormal positioning of the occiput.
2) Causes of malpresentations can include faults in the powers (weak uterine contractions), faults in the passages (abnormal pelvis), or faults in the passenger (fetal anomalies). Specific causes mentioned include contracted pelvis, uterine anomalies, large fetus size, and placenta previa.
3) Diagnosis involves history of abnormal fetal movements, abdominal exam findings like non-engaged head, and vaginal exam finding anything other than vertex. Comp
The document discusses normal labor, defining it as the spontaneous expulsion of a single, term fetus through the birth canal within 3-24 hours without complications. It describes the stages and physiology of labor, including the onset of labor, cervical dilation and fetal descent in the first stage, expulsion in the second stage, and placental delivery in the third stage. The summary also covers the diagnosis and management of normal labor.
This document discusses methods for estimating gestational age, which is important for optimizing fetal surveillance and timing tests and activities. Gestational age can be estimated through history (last menstrual period, fertility treatments), clinical exam (bimanual exam, fundal height, abdominal girth), and ultrasound imaging. Ultrasound is the most accurate method, where early pregnancy ultrasounds using crown-rump length are very accurate for dating. Later in pregnancy, biparietal diameter, head circumference, femur length, and abdominal circumference are used but decrease in accuracy over time. Precise gestational age estimation optimizes care and diagnosis of fetal growth abnormalities.
This document provides guidelines for the prevention of surgical site infections from various medical institutions including the CDC. It discusses the epidemiology of surgical site infections, including risk factors like increased length of stay and mortality. It also covers pathogenesis, classification of wounds, and provides evidence-based recommendations for preventing infections through practices like parenteral antimicrobial prophylaxis, glycemic control, normothermia, oxygenation, antiseptic prophylaxis and more. The goal is to incorporate these guidelines into surgical quality improvement programs to enhance patient safety.
The document discusses endometrial hyperplasia and its management. It recommends following the revised 2014 WHO classification of endometrial hyperplasia. For endometrial hyperplasia without atypia, it recommends initial counseling followed by observation alone or medical treatment with progestogens. The levonorgestrel-releasing IUD is the preferred first-line medical treatment. Treatment should be for a minimum of 6 months followed by endometrial biopsies every 6 months to confirm regression before discharge. Hysterectomy is not first-line treatment and is only indicated if hyperplasia progresses or does not regress with treatment.
This document discusses pelvic adhesions, which are scar tissues that form after abdominal surgery, infections, or endometriosis. It covers the epidemiology, pathophysiology, risk factors, diagnosis, classification, causes of infertility, prevention, and treatment of pelvic adhesions. Adhesions are commonly treated through laparoscopic or microsurgical adhesiolysis to relieve pain and improve fertility outcomes.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
pathology MCQS introduction to pathology general pathology
Impact of male factor on recurrent pregnancy loss
1. Impact
of
male
factor
on
recurrent
pregnancy
loss
Osama
M
Warda
MD
Prof.
of
obstetrics
and
gynecology
Mansoura
university
2. Background
• Recurrent
pregnancy
loss
(RPL)
is
tradi=onally
defined
as
3
or
more
consecu=ve
pregnancy
losses(RCOG),
OR
as
2
or
more
consecu=ve
pregnancy
losses
(ACOG).
• Greater
than
50%
of
cases
remain
unexplained,
even
aLer
an
extensive
workup
(Puschecka
&
Jeyendranb
2007).
• The
en=re
evalua=on
focuses
on
the
female,
with
the
excep=on
of
gene=cs
of
the
products
of
concep=on
and
gene=cs
of
the
individuals
of
the
couple.
osama
warda
2
3. Background
• The
female
evalua=on
may
reveal
one
of
the
following
major
causes:
1-‐
Endocrine
causes,
2-‐
Anatomical
causes;
uterine
defects,
3-‐
Infec;ous
causes,
4-‐
Immunological
causes,
5-‐
Gene;c
causes,
6-‐Thrombophilia.
• Gene;c
abnormali=es
are
the
commonest
cause
of
spontaneous
miscarriage
cons=tu=ng
about
50%
of
cases.
osama
warda
3
4. Background
• Gene=c
abnormali=es
within
the
individuals
of
the
couple
occur
in:
-‐
1–4%
of
couples
with
RPL
-‐
0.7%
of
the
general
popula=on
(
Li
TC
et
al
2002)
osama
warda
4
5. Background
• The
gene=c
evalua=on
of
the
products
of
concep=on
and
of
the
couple
typically
consists
only
of
the
karyotypes.
• A
karyotype
includes
an
evalua=on
of
the
number
of
chromosomes
and
any
large
dele;ons,
duplica;ons
or
transloca;ons.
(Puschecka
E
&
Jeyendranb
R
2007)
osama
warda
5
6. Background
• The
most
common
karyotype
abnormali=es
that
are
iden=fied
within
the
products
of
concep=on
are
missing
or
addi;onal
chromosomes.
• These
assays
will
not
detect
small
dele;ons,
subs;tu;ons,
duplica;ons,
transloca;ons
or
point
muta;ons.
(These
smaller
gene;c
disorders
may
account
for
many
more
of
these
miscarriages).
osama
warda
6
7. Male
as
a
poten9al
cause
of
RPL
• It
would
make
sense
that
recurrent
pregnancy
loss
may
have
a
male
factor
since
the
male
gamete
contributes
one-‐half
of
the
genomic
content
to
the
embryo.
osama
warda
7
8. Male
as
a
poten9al
cause
of
RPL
• karyotype
of
the
male
was
the
only
evalua=on
done
.
• The
gene=cs
of
recurrent
abor=on
may
result
from
two
chromosomal
abnormali=es:
1-‐
a
structural
abnormality
derived
from
one
parent
(transloca;on,
inversions,
etc.);
or
2-‐
the
occurrence
of
a
numerical
abnormality
(extra
or
missing
chromosome),
which
is
usually
not
inherited.
osama
warda
8
9. Male
as
a
poten9al
cause
of
RPL
• Animal
studies;
The
male
genome
contributes
more
to
the
placenta
than
the
female
genome.
-‐
In
androgenodes
(pregnancy
conceived
with
two
male
gametes)
the
pregnancy
consists
of
en=rely
placenta,
whereas;
-‐
in
gynegenodes
(pregnancy
conceived
from
two
female
gametes)
the
pregnancy
results
in
an
embryo
with
no
or
very
li]le
placenta.
(Spindle
et
al
1996)
osama
warda
9
10. Male
as
a
poten9al
cause
of
RPL
• Animal
studies:
The
findings
from
mouse
studies
suggest
that
the
male
may
be
important
for
decidual
vascular
remodeling
and
this
mechanism
may
not
occur
or
may
be
abnormal
in
some
cases
of
recurrent
pregnancy
loss
(Dixon
et
al.
2006)
osama
warda
10
11. Possible
Male
causes
of
RPL
(2)
Sperm
factors
(a)
Sperm
chromosome
(i)
Structural
abnormality
(ii)
Numerical
abnormality
(b)
Gene
muta9ons
(i)
HLA-‐G
polymorphisms
(ii)
Thrombophilia
muta=ons
(iii)
Microdele=ons
of
the
Y
chromosome
(c)
Sperm
quality
(1) Chromosomal
abnormali9es;
karyotyping
(a)
Structural
abnormali9es
(
transloca9ons)
(b)
Numerical
abnormali9es
osama
warda
11
(4)
Miscellaneous
factors
(a)
Mannan
binding
protein
(MBP)
(b)
Therapeu=c
agents
(c)
Others
(3)
Paternal
age
12. Possible
Male
causes
of
RPL
(1) Chromosomal
abnormali9es;
(a)
Structural
abnormali9es
(b)
Numerical
abnormali9es
osama
warda
12
13. osama
warda
13
This
study
demonstrated
a
strong
associa9on
between
RPL
and
the
prevalence
of
chromosomal
abnormali9es
and
inherited
thrombophilia.
Given
the
high
rate
of
consnguineous
marriages
in
the
Saudi
popula9on,
these
results
underline
the
importance
of
systemic
cytogene9c
inves9ga9on
and
gene9c
counselling
preferably
at
the
premarital
stage
or
at
least
during
early
pregnancy
phase
through
PGD
14. CONCLUSION:
Couples
with
pregnancy
loss
produce
chromosomally
abnormal
embryos
in
a
significantly
higher
percentage
than
those
not
having
this
reproduc;ve
problem
which
are
mainly
due
to
non-‐dysjunc;on.
Once
an
unbalanced
transloca;on
in
the
(fetus
/
child
)has
been
iden;fied,
parental
karyotype
is
essen;al.
osama
warda
14
15. A
total
of
495
couples
were
included
in
the
study.
Mean
age
of
the
female
pa=ents
was
30.6
years
(range:
19–44).
Parental
chromosome
analysis
was
performed
in
all
of
the
495
couples.
Among
these
990
subjects,
a
major
chromosomal
abnormality
was
detected
in
28
cases
(2.8%
of
all
cases,
5.7%
of
the
couples)
.
16
(57.1%)
of
the
abnormali;es
were
in
females,
and,
12
(42.9)
of
the
abnormali=es
were
in
males.
osama
warda
15
16. Structural
Chromosomal
Abnormali=es
Transloca=ons
-‐
Reciprocal
transloca;ons
are
usually
an
exchange
of
material
between
non-‐homologous
chromosomes.
-‐
Robertsonian
transloca;on
is
a
type
of
transloca=on
caused
by
breaks
at
or
near
the
centromeres
of
two
acrocentric
chromosomes.
The
reciprocal
exchange
of
parts
gives
rise
to
one
large
metacentric
chromosome
and
one
extremely
small
chromosome
that
may
be
lost
from
the
organism
with
li]le
effect
because
it
contains
so
few
genes.
The
resul=ng
karyotype
in
humans
leaves
only
45
chromosomes,
since
two
chromosomes
have
fused
together.
osama
warda
16
18. Structural
Chromosomal
Abnormali9es
• If
the
re-‐arrangement
of
the
chromosomes
results
in
crea=ng
gametes
with
unbalanced
transloca;ons,
then
the
resul=ng
offspring
typically
do
not
result
in
live
births
but
abort.
• Couples,
where
one
or
both
carry
a
balanced
transloca=on,
are
at
higher
risk
for
miscarriage
due
to
the
fact
that
they
may
produce
balanced
or
unbalanced
gametes.
osama
warda
18
19. Structural
Chromosomal
Abnormali=es
• Balanced
transloca=ons
are
associated
with
reduced
pregnancy
rates
and
increased
miscarriages.
• The
es=mated
incidence
of
Robertsonian
transloca=on
is
about
0.1%
in
the
general
popula=on
[Morel
&
Bresson
2001].
• In
couples
with
recurrent
abor=on,
the
prevalence
is
reported
as
high
as
approximately
8%
[Sugiura
et
al
2004]
osama
warda
19
20. Structural
Chromosomal
Abnormali=es
•
Men
with
a
transloca=on
can
have
gametes
with
a
normal,
a
balanced
or
an
unbalanced
complement
of
chromosomes
that
can
lead
to
normal,
balanced
or
unbalanced
offspring.
• If
one
parental
carrier
has
a
21q21q
transloca=on
or
iso-‐chromosome,
then
there
is
a
100%
recurrence
risk
of
trisomy
21
–
and
about
50
–
80%
risk
of
trisomy
21
fetuses
result
in
miscarriage
[Leporrier
et
al
2003]
osama
warda
20
21. Structural
Chromosomal
Abnormali=es
• A
Japanese
study
[Sugiura
et
al
2004]
of
1,284
recurrent-‐loss
couples
revealed
higher
miscarriage
rates
associated
with
the
male
as
the
carrier
of
the
abnormal
karyotype
In
these
cases,
men
with
reciprocal
transloca=ons
had
a
61.1%
miscarriage
rate,
men
with
Robertsonian
transloca=ons
had
a
36.4%
miscarriage
rate,
and
men
with
inversions
had
a
miscarriage
rate
of
28
–
42.9%.
• They
concluded
that
“The
pregnancy
prognosis
with
either
maternal
or
paternal
reciprocal
transloca;ons
is
poorer
than
without
them.
The
presence
of
a
reciprocal
transloca;on
is
thus
a
risk
factor
in
couples
who
have
recurrent
miscarriages.”
osama
warda
21
22. Numerical
chromosomal
abnormali=es
• Chromosomal
abnormali=es
involving
an
abnormal
number
of
chromosomes
typically
result
in
miscarriage
when
this
occurs
in
the
fetus;
living
men
may
have
an
extra
chromosome.
• The
more
common
of
these
disorders
include
Down’s
syndrome
(trisomy
21;
incidence
1
in
600)
and
Kleinfelter’s
syndrome
(47,
XXY;
incidence
1
in
2000).
Most
of
these
men
are
thought
to
have
significantly
reduced
fer=lity
or
sterility
and
high
miscarriage
rates
of
50%
or
more
[Leporrier
et
al
2003]
.
osama
warda
22
23. osama
warda
23
Fer=lity
associa=on
of
Memphis
–USA
(2017)
24. Chromosomal
rearrangements
were
found
in
170
individuals
(3.5%).
Transloca;ons
were
seen
in
72
(42.35%)
cases.
Of
these,
reciprocal
transloca=ons
cons=tuted
42
(24.70%)
cases
while
Robertsonian
transloca=ons
were
detected
in
30
(17.64%)
cases.
7
(4.11%)
cases
were
mosaic,
8
(4.70%)
had
small
supernumerary
marker
chromosomes
and
1
(0.6%)
had
an
inters==al
microdele=on.
Nearly,
78
(1.61%)
cases
with
heteromorphic
variants
were
seen
of
which
inversion
of
Y
chromosome
(57.70%)
and
chromosome
9
pericentromeric
variants
(32.05%)
were
predominantly
involved.
osama
warda
24
25. Conclusion
:
Gene=c
variables
appear
to
play
a
complex
role
in
the
efficiency
of
human
reproduc=on.
Classically,
high
rates
of
chromosomal
errors
have
been
among
the
leading
e9ologies
for
fetal
loss
and
more
recent
studies
have
begun
to
highlight
the
important
role
that
specific
single
gene
defects
may
play
in
pregnancy
maintenance.
PGD
may
be
indicated
in
a
small
propor;on
of
couples
with
defined
transloca;ons
or
select
single
gene
disorders.
osama
warda
25
26. (2)
Sperm
factors
(a)
Sperm
chromosome
(i)
Structural
abnormality
(ii)
Numerical
abnormality
(b)
Gene
muta9ons
(i)
HLA-‐G
polymorphisms
(ii)
Thrombophilia
muta=ons
(iii)
Microdele=ons
of
the
Y
chromosome
(c)
Sperm
quality
osama
warda
26
27. CONCLUSION:
Semen
profile
and
sperm
func=on
tests
scores
were
significantly
lower
in
the
RPL
group
when
compared
to
the
control
group.
Through
this
pilot
study
it
is
significant
that
male
factor
might
be
a
possible
contribu;ng
factor
towards
RPL.
Apart
from
rou;ne
semen
analysis,
sperm
func;on
tests
may
be
an
informa;ve
tool
in
cases
of
idiopathic
RPL.
Therefore
both
the
partners
should
be
evaluated
and
treated
simultaneously
in
order
to
achieve
successful
pregnancy.
osama
warda
27
28. osama
warda
28
Conclusion
:
this
study
concluded
that
there
is
a
posi9ve
associa9on
of
sperm
dysfunc9on
with
RPL,
hence
male
can
be
considered
for
rou9ne
evalua9on
along
with
the
female
in
order
to
achieve
desirable
outcome
29. Sperm
chromosome:
numerical
abnormality
• In
current
prac=ce
it
is
possible
to
study
the
karyotypes
of
peripheral
white
blood
cells
from
men
whose
wives
have
recurrent
pregnancy
as
well
as
to
analyze
the
germline
in
the
gamete:
individual
sperm
chromosomes.
• Rubio
et
al.
[1999]
studied
12
sperm
samples
from
couples
with
two
or
more
first-‐trimester
losses
who
were
under-‐
going
IVF
.
They
found
that
sex
chromosome
diosmy
and
diploidy
significantly
higher
than
control.
This
implicates
the
impact
of
paternal
effects
despite
the
age
of
the
female.
osama
warda
29
30. osama
warda
30
This
study
suggests
that
polymorphic
variants
have
an
impact
on
fer=lity.
Moreover,
the
results
show
a
rela=onship
between
polymorphisms
and
aneuploidy
in
spermatozoa
and
embryos.
31. Sperm
chromosome:
numerical
abnormality
• Carrell
et
al.
[2003]
reported
a
sta;s;cally
higher
mean
sperm
aneuploidy
rate
in
men
of
unexplained
recurrent
miscarriage
couples
than
in
the
general
popula;on
or
fer;le
controls.
Addi=onally,
they
found
that
the
percentage
of
aneuploid
sperm
was
correlated
to
the
percentage
of
apopto=c
sperm
using
a
TUNEL
assay
.
• DNA
fragmenta;on
is
a
hallmark
of
apoptosis
in
human
sperm.
Many
Studies
showed
increased
apoptosis
in
the
semen
of
infer=le
men
and
increased
abnormal
sperm
morphology
inversely
correlated
with
IVF
outcome.
osama
warda
31
32. Sperm
chromosome:
structural
abnormality
• The
sperm
chroma;n
structure
assay
measures
increased
sperm
chroma=n
suscep=bility
to
acid
denatura=on
(Evenson
et
al
1999,
Spano
et
al
2000)
• Higher
sperm
chroma=n
structure
assay
values
predict
39%
of
miscarriages
[Evenson
et
al
1999].
• In
studies
correla=ng
sperm
DNA
integrity
and
outcomes
of
IVF
cycles
;
The
spontaneous
miscarriage
rate
is
increased
in
ICSI
cycles
when
pa=ents
with
known
meio;c
disorders
associated
with
increased
frequencies
of
diploidy
are
compared
with
controls
[Aran
et
al
1999].
osama
warda
32
34. osama
warda
34
In
men
with
aneuploidy
in
sperm
or
who
carry
a
chromosomal
transloca=on,
pre-‐implanta=on
gene=c
screening
(PGS)
combined
with
in
vitro
fer=liza=on
(IVF)
and
intra-‐cytoplasmic
sperm
injec=on
(ICSI)
can
increase
chances
of
live
birth.
35. osama
warda
35
Men
with
RPL
have
increased
sperm
aneuploidy
compared
with
controls.
A
total
of
40%
of
men
with
RPL
and
normal
sperm
density/mo=lity
had
abnormal
sperm
aneuploidy.
Men
with
oligo-‐asthenozoospermia
and
abnormal
strict
morphology
had
a
greater
percentage
of
sperm
aneuploidy
compared
with
men
with
normal
semen
parameters.
36. osama
warda
36
Conclusion
:
Protamine-‐1
and
protamine-‐2
mRNA
levels
as
well
as
the
protamine
mRNA
ra=o
and
all
rou=ne
semen
parameters
revealed
significant
differences
between
recurrent
miscarriage
couples
and
healthy
volunteers
(P
<
0.01)
37. osama
warda
37
The
increase
in
abnormal
sperm
parameters,
sperm
DNA
fragmenta=on,
nuclear
chroma=n
decondensa=on,
and
sperm
aneuploidy
suggest
possible
causes
of
unexplained
RPL.
38. Gene
muta=ons
• Gene
muta=ons
may
occur
in
any
gene.
The
muta=ons
may
be
a
single
point
muta;on
resul=ng
in
an
amino
acid
change
or
they
may
be
dele;ons
or
subs;tu;ons
or
inser;ons
• common
gene
muta=ons
associated
with
miscarriage
include:
1-‐HLA-‐G
polymorphisms
(Aldrich
et
al
2001)
2-‐
Thrombophilia
muta=ons
(Jivraj
et
al
2006)
3-‐
Microdele=on
of
the
Y
chromosome
(Dewan
et
al
2006)
osama
warda
38
39. Sperm
Quality
• Evidence
is
accumula=ng
for
paternal
genome
effects
in
early
embryonic
development.
Sperm
integrity
is
vital
for
sperm
–
egg
interac=ons,
fer=liza=on
and
early
embryonic
development
(Tesarik
et
al
2004).
• The
paternal
genome
provides
the
centrosome
in
the
first
mito=c
division
aLer
fer=liza=on
(Sathananthan
AH
1997).
• Sperm
quality
has
been
associated
with
the
embryo’s
ability
to
reach
the
blastocyst
stage
and
progress
to
implanta=on.
Paternally
expressed
genes
modulate
the
prolifera=on
and
invasiveness
of
trophoblast
cells
and
later
placental
prolifera=on
(Tesarik
et
al
2004).
osama
warda
39
40. Sperm
Quality
-‐ One
study
found
a
rela=on
between
tapered
sperm
morphology
and
unexplained
recurrent
miscarriage
(
Sbracia
et
al
1996).
-‐ Another
study
found
correla=on
with
hypoosmo;c
swelling
test
scores
in
the
recurrent
miscarriage
(Bucke[
et
al
1997)
-‐ A
3rd
study
found
an
associa=on
with
poor
sperm
quality
and
repeated
early
pregnancy
loss
as
measured
by
an
increase
in
sperm
nuclear
vacuoles
or
abnormal
chroma;n
condensa;on
(Gopalkkrishnan
et
al.
2000)
.
osama
warda
40
41. Possible
Male
causes
of
RPL
osama
warda
41
(4)
Miscellaneous
factors
(a)
Mannan
binding
protein
(MBP)
(b)
Therapeu=c
agents
(c)
Others
(3)
Paternal
age
42. Paternal
age
• Cytogene=c
analysis
of
semen
specimens
from
donors
demonstrates
increased
frequency
of
numerical
and
structural
chromosome
aberra;ons
in
the
sperm
from
men
59
–
74
years
old
compared
with
sperm
from
men
who
are
23–29years
old
(Kleinhaus
et
al
2006︎).
• The
risk
of
miscarriage
increased
steadily
with
paternal
age
of
40
years
and
older,
especially
if
the
mother
is
35
years
or
older
(De
La
Rochebrochard
et
al
2003)
.
osama
warda
42
43. Paternal
age
• A
Danish
study
showed
a
two-‐fold
increase
in
early
fetal
death
when
the
father
was
over
50
years.
• There
is
an
associa=on
between
paternal
age
and
the
frequency
of
the
sperm
DNA
fragmenta;on
index
.
In
general,
a
high
DNA
fragmenta=on
index
(>
30%)
is
associated
with
reduced
fer=lity
and
a
low
live
birth
rate,
and
with
a
high
miscarriage
rate.
(
Wyrobek
et
al.
2006︎)
.
osama
warda
43
44. Paternal
age
• Paternal
age
is
also
associated
with
gain-‐of-‐
func;on
muta;ons
within
sperm
that
have
detrimental
effects
on
embryos.
These
muta=ons
occur
in
3
iden=fied
hot
spots:
FGFR2,
FGFR3,
and
RET.
These
genes
encode
for
tyrosine
kinase
receptors
.
Each
of
these
muta=ons
is
associated
with
an
autosomal
dominant
effect
on
the
progeny
(achondroplasia,
Apert’s
syndrome,
etc.)
–
if
they
survive
to
delivery.
(
Crow
JF,
2003)
osama
warda
44
45. Miscellaneous
factors
• Addi=onal
factors
that
may
affect
sperm
and
recurrent
pregnancy
loss
include
the
following:
(1)
Mannan
binding
protein
(2)
Therapeu=c
agents
(3)
others
osama
warda
45
46. Mannan
Binding
Protein
(MBP)
• There
is
associa=on
between
a
deficiency
in
MBP
protein
in
either
male
or
female
partner
and
recurrent
miscarriages.
(Kilpatrick
et
al
1995).
This
associa=on
was
stronger
when
the
individuals
were
homozygous
for
the
mutant
allele
responsible
for
MBP
deficiency.
At
a
cut-‐
off
level
value
of
MBP
=
0.6
the
recurrent
pregnancy
loss
was
35%
(Kilpatrick
et
al
1999).
osama
warda
46
47. Therapeu=c
agents
• Ionizing
radia=on,
air
pollu=on,
and
other
environmental
exposures
have
been
implicated
in
inducing
muta;ons
or
sperm
aneuploidy
(
Puschecka
E
&
Jeyendranb
2007).
•
Medical
treatment
(i.e.
chemotherapy
and
radia=on)
for
cancer
treatment
can
increase
the
mutagenic
rate
of
sperm
DNA
(Puschecka
et
al
2004).
osama
warda
47
48. Therapeu=c
agents
• Some
studies
reported
that
the
nucleoside
analog
reverse
transcriptase
inhibitor
exposure,
typically
used
to
treat
HIV
and
other
retroviral
disorders
,
could
induce
an
altera=on
on
the
mitochondrial
energy-‐
genera=ng
ability
of
spermatozoa
leading
to
increased
sperm
DNA
fragmenta=on
and
eventually
recurrent
pregnancy
loss
(Sergerie
et
al.204)
.
osama
warda
48
49. CONCLUSION
• The
appropriate
management
for
male
partners
of
couples
with
recurrent
pregnancy
loss
(RPL)
or
recurrent
implanta=on
failure
during
in
vitro
fer=liza=on
(IVF)
remains
unclear.
•
Despite
normal
semen
parameters,
male
partners
in
couples
with
RPL
or
recurrent
implanta=on
failure
could
have
underlying
gene=c
abnormali=es
in
sperm
DNA
that
can
be
iden=fied.
(
Dickey
&
Ramasamy2015)
osama
warda
49
50. CONCLUSION
• There
are
a
couple
of
diagnos=c
tests
that
we
recommend
in
the
evalua=on
of
these
men,
the
first
being
DNA
Fragmenta=on
Index
(DFI)
and
the
second,
fluorescence
in
situ
hybridiza=on
(FISH)
for
evalua=ng
sperm
aneuploidy.
• Taken
together,
both
DFI
and
FISH
tes=ng
are
recommended
in
the
work-‐up
of
male
factor
in
couples
with
recurrent
pregnancy
loss
or
recurrent
IVF
failure.
osama
warda
50
51. CONCLUSION
• Men
with
increased
DFI
in
ejaculated
sperm
may
be
counseled
for
a
tes=cular
biopsy
in
combina=on
with
ICSI,
•
Those
with
increased
sperm
aneuploidy
can
be
advised
to
undergo
IVF
combined
with
PGS.
osama
warda
51
52. CONCLUSION
• High
magnifica=on
ICSI
(
=
IMSI):
in
a
Cochrane
review
authors
concluded
that
results
from
RCTs
do
not
support
the
clinical
use
of
IMSI.
There
is
no
evidence
of
effect
on
live
birth
or
miscarriage
and
the
evidence
that
IMSI
improves
clinical
pregnancy
is
of
very
low
quality
(Teixeira
et
al
2013)
osama
warda
52
53. CONCLUSIONS
• An=oxidants
may
help
to
reduce
sperm
DNA
fragmenta=on
rates
,
hence
lower
pregnancy
loss
rates
(Greco
et
al
2005).
osama
warda
53